BioSpace News Archive

Business

iECURE Bolsters Senior Management Team with Appointment of David Garrett as Chief Financial Officer

iECURE adds Kim Smith as vice president of finance and Ashley Kim as director of business development.

December 6, 2021
·
3 min read
Genetown

Nearly 15% of Prescribing U.S. Rheumatologists Use Scipher Medicine’s PrismRA® Blood Test Since Its Launch A Year Ago

Nearly 15% of Prescribing U.S. Rheumatologists Use Scipher Medicine’s PrismRA ® Blood Test Since Its Launch A Year Ago.

December 6, 2021
·
4 min read
Genetown

PharmaEssentia’s BESREMi® (ropeginterferon alfa-2b-njft) Now Available for the Treatment of People With Polycythemia Vera in the United States

PharmaEssentia’s BESREMi ® (ropeginterferon alfa-2b-njft) Now Available for the Treatment of People With Polycythemia Vera in the United States.

December 6, 2021
·
14 min read
Drug Development

180 Life Sciences Provides Follow-Up Information on Oxford University and the Company’s Successful Dupuytren’s Phase 2b Clinical Trial Results

180 Life Sciences Corp. today provided follow-up information on the top line results of Oxford University and the Company’s Phase 2b clinical trial for Dupuytren’s disease announced on December 1, 2021.

December 6, 2021
·
8 min read
Drug Development

Cyclo Therapeutics Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease

Cyclo Therapeutics Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Trappsol ® Cyclo™ for the Treatment of Alzheimer’s Disease.

December 6, 2021
·
6 min read
Biotech Bay

Guardant Health Presents Data Demonstrating Utility of Comprehensive Genetic Profiling with Guardant360® Liquid Biopsy Test to Guide Treatment for Advanced Breast Cancer Patients at 2021 San Antonio Breast Cancer Symposium

sGuardant Health, Inc. announced it will present new data demonstrating the benefits of using the Guardant360® liquid biopsy test to help guide targeted therapy options for patients with advanced breast cancer at the 2021 San Antonio Breast Cancer Symposium on December 7-11.

December 6, 2021
·
6 min read
Biotech Beach

Emmaus Life Sciences’ Data on Endari® Accepted for Poster Presentation at the 63rd American Society of Hematology Annual Meeting & Exhibition

Emmaus Life Sciences, Inc. (OTCQX: EMMA), today announced that data on Endari®, the company’s prescription L-glutamine oral powder for the treatment of sickle cell disease, has been accepted for a poster presentation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exhibition.

December 6, 2021
·
3 min read
Genetown

Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that management will participate at the Benzinga Global Small Cap Conference on December 9, 2021.

December 6, 2021
·
1 min read
Drug Development

PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationInstitutional Review Board (IRB) approval has been obtained and clinical trial recruitment resumes

PDS Biotechnology Corporation (Nasdaq: PDSB), today announced the reopening of recruitment in the National Cancer Institute (NCI)-led Phase 2 clinical trial (NCT04287868) evaluating PDS0101 (Versamune®-HPV16) in combination with two investigational immune-modulating agents in advanced HPV cancers.

December 6, 2021
·
7 min read
Drug Development

Upadacitinib (RINVOQ®) Achieved Primary and Key Secondary Endpoints in First Phase 3 Induction Study in Patients with Crohn’s Disease

AbbVie (NYSE: ABBV) today announced positive top-line results from U-EXCEED, a Phase 3 induction study, showing upadacitinib (45 mg once daily) achieved both primary endpoints of clinical remissiona,b and endoscopic responsec at week 12.1.

December 6, 2021
·
20 min read